D. E. Shaw & Co »

Bridgebio Pharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $107M 63M 1.70

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Bridgebio Pharma

D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
CSS
Alberta Investment Management Corporation
Calamos Advisors
Ameriprise Financial
Wolverine Asset Management
SSI Investment Management
Bank of America Corporation
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Bridgebio Pharma